// App-Quantinova.ai

2103-314 : THREE-YEAR CLINICAL OUTCOME COMPARISON BETWEEN EVEROLIMUS- VERSUS ZOTAROLIMUS-ELUTING STENTS IN ALL-COMERS AND DIABETICS

Researchers

Presenter

  • Shaopeng Xu

Principal Investigators

  • Seung-Woon Rha

  • Byoung Geol Choi

  • Jin Won Kim

  • Eung Ju Kim

  • Se Yeon Choi

  • Harris Ngow Abdullah

  • Jae Joong Lee

  • Sunki Lee

  • Ji Bak Kim

  • Jin oh Na

  • Cheol Ung Choi

  • Hong Euy Lim

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Complex calcified coronary artery lesions

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim